733 CONCORD AVENUE
August 8, 2022
CPI/King 733 Concord Owner, LLC, a Delaware limited liability company (as successor-in-interest to King 733 Concord LLC, a Delaware limited liability company)
Wave Life Sciences USA, Inc., a Delaware corporation
Approximately 44,019 rentable square feet of space, in the aggregate, consisting of: (i) approximately 30,893 rentable square feet of space in the Building (the “Original Premises”), and (ii) approximately 13,126 rentable square feet of space on the first (1st) floor of the Building (the “ROFO Premises”), both, as more particularly described in the Existing Lease (as defined below).
DATE OF EXISTING LEASE:
April 6, 2015
CURRENT EXPIRATION DATE OF ORIGINAL PREMISES:
EXTENDED EXPIRATION DATE FOR ORIGINAL PREMISES:
EXPIRATION DATE FOR ROFO PREMISES:
PRIOR AMENDMENTS/SUPPLEMENTS TO LEASE:
March 31, 2023
March 31, 2028
September 30, 2026
Commencement Letter dated October 1, 2015
WHEREAS, Tenant desires to extend the Term of the Lease with respect to the Original Premises for an additional period; and
WHEREAS, Landlord is willing to extend the Term of the Lease with respect to the Original Premises for an additional period, upon the terms and conditions hereinafter set forth.
NOW, THEREFORE, the Existing Lease, as previously amended, is hereby further amended by this Second Amendment (the Existing Lease, as previously amended, and as further amended by this Second Amendment, shall hereafter be referred to as the “Lease”). Any capitalized terms used herein shall have the same definition as set forth in the Existing Lease, except to the extent otherwise set forth in this Second Amendment.
Period of Time
Annual Base Rent
Monthly Base Rent
[Signature Page Follows]
EXECUTED as of the date first above written.
CPI/KING 733 CONCORD OWNER, LLC,
a Delaware limited liability company
By: /s/ Thomas Ragno__________________
Name: Thomas Ragno________________
Title: Authorized Signatory__________
WAVE LIFE SCIENCES USA, INC.
a Delaware corporation
By: /s/ Kyle Moran_____________________
Name: Kyle Moran___________________
Title: Chief Financial Officer___________